**Author details**

Yingai Shi1 , YuLin Li1 , JinYu Liu1 and Yuanyuan Zhang2\*

\*Address all correspondence to: yzhang@wakehealth.edu

1 Key Laboratory of Pathobiology, Ministry of Education, Jilin University, Changchun, Chi‐ na

2 Wake Forest Institute for Regenerative Medicine, Winston-Salem, NC, USA

### **References**


[19] Lin, C. S, & Lue, T. F. (2012). Stem cell therapy for stress urinary incontinence: a criti‐ cal review. *Stem Cells Dev 21*(6), 834-843.

[7] Delancey, J. O. (2010). Why do women have stress urinary incontinence? *Neurourol*

[8] Shamliyan, T. A, Kane, R. L, Wyman, J, & Wilt, T. J. (2008). Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in

[9] Kerr, L. A. (2005). Bulking agents in the treatment of stress urinary incontinence: his‐ tory, outcomes, patient populations, and reimbursement profile. *Rev Urol* 7 Suppl

[10] Xu, Y. M, Zhang, X. R, Sa, Y. L, Chen, R, & Fei, X. F. (2007). Bulbourethral composite suspension for treatment of male-acquired urinary incontinence. *Eur Urol 51*discus‐

[11] Hinoul, P, Roovers, J. P, Ombelet, W, & Vanspauwen, R. (2009). Surgical manage‐ ment of urinary stress incontinence in women: a historical and clinical overview. *Eur*

[12] Smaldone, M. C, Chen, M. L, & Chancellor, M. B. (2009). Stem cell therapy for ure‐

[13] Kinebuchi, Y, Aizawa, N, Imamura, T, Ishizuka, O, Igawa, Y, & Nishizawa, O. (2010). Autologous bone-marrow-derived mesenchymal stem cell transplantation into in‐

[14] Drost, A. C, Weng, S, Feil, G, Schäfer, J, Baumann, S, Kanz, L, Sievert, K. D, Stenzl, A, & Möhle, R. (2009). In vitro myogenic differentiation of human bone marrow-derived mesenchymal stem cells as a potential treatment for urethral sphincter muscle repair.

[15] Dezawa, M, Ishikawa, H, Itokazu, Y, Yoshihara, T, Hoshino, M, Takeda, S-i, Ide, C, & Nabeshima, Y-i. (2005). Bone marrow stromal cells generate nuscle cells and repair

[16] Kocaefe, C, Balci, D, Hayta, B. B, & Can, A. (2010). Reprogramming of human umbili‐ cal cord stromal mesenchymal stem cells for myogenic differentiation and muscle re‐

[17] Lin, G, Wang, G, Banie, L, Ning, H, Shindel, A. W, Fandel, T. M, Lue, T. F, & Lin, C. S. (2010). Treatment of stress urinary incontinence with adipose tissue-derived stem

[18] Mizuno, Y, Chang, H, Umeda, K, Niwa, A, Iwasa, T, Awaya, T, Fukada, S, Yamamo‐ to, H, Yamanaka, S, Nakahata, T, & Heike, T. (2010). Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells. *FASEB J 24*(7),

thral sphincter regeneration. *Minerva Urol Nefrol 61*(1), 27-40.

jured rat urethral sphincter. *Int J Urol 17*(4), 359-368.

muscle degeneration. *Science 309*(5732), 314-317.

*Urodyn* 29 Suppl 1(S, 13-17.

792 Regenerative Medicine and Tissue Engineering

sion 1715-1706.(6), 1709-1714.

*Ann NY Acad Sci 1176*(1), 135-143.

pair. *Stem Cell Rev 6*(4), 512-522.

cells. *Cytotherapy 12*(1), 88-95.

2245-2253.

1(SS11., 3.

women. *Ann Intern Med 148*(6), 459-473.

*J Obstet Gynecol Reprod Biol 145*(2), 219-225.

